Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
丰百盛默（Bettermore） is a Shanghai-based HR recruitment consulting and executive search firm focused on the healthcare and life sciences industry. According to the website, the company has been operating since 2009, with services covering pharmaceuticals, biotechnology, commercial teams, medical affairs, clinical development, R&D, and other areas. It has a network in cities such as Beijing, Xi’an, and Hangzhou, as well as a wholly owned subsidiary in Seattle, with a Los Angeles office planned for 2025.
Based on publicly available information, 丰百盛默’s core offering is not a SaaS product, but consultant-led recruitment services. Its strengths center on sourcing mid-to-senior management talent and industry experts, candidate management, motivation assessment, informal background checks, and sharing market and talent intelligence. The team is segmented by business area, including commercial teams, medical affairs and clinical development, and R&D. It particularly emphasizes its expertise in drug development, clinical research, and pharmaceutical commercial roles, and claims to be able to proactively reach a large number of passive candidates.
The website does not disclose service packages, pricing models, contract structures, or payment methods. It also does not show common SaaS or enterprise software features such as a free trial, online recruitment system, client dashboard, API, third-party integrations, permission management, or data security certifications. Therefore, if evaluated as enterprise software, its level of productization and transparency is relatively weak. If evaluated as an executive search service, it is better suited for obtaining customized quotes through offline communication.
Its strengths lie in its clear vertical industry focus, long-term service in the healthcare sector, and endorsements from RECC as well as clients or industry awards involving companies such as BeiGene, Eli Lilly, MSD, GSK, Zai Lab, and AstraZeneca. Team stability is also disclosed, with an employee turnover rate of less than 10%. The drawbacks are that the publicly available information leans more toward brand presentation and lacks quantifiable indicators such as delivery timelines, success rates, candidate database size, and compliance mechanisms. It also does not demonstrate publicly verifiable software capabilities.
It is suitable for pharmaceutical companies, biotech firms, multinational pharmaceutical companies, innovative drug companies, and healthcare companies expanding overseas that need mid-to-senior-level recruitment, especially for R&D, clinical, medical affairs, and commercial roles. The website has an ICP filing and is oriented toward the Chinese market, so it can usually be accessed directly from within China.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bettermorechina.com official site.
bettermorechina.com is an China Hiring & Remote provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach bettermorechina.com directly.